Guaifenesin as a Treatment for Primary Dysmenorrhea

References

1. ↵
   Coco AS. Primary dysmenorrhea. Am Fam Physician 1999; 60: 489–96.

   OpenUrlPubMedWeb of Science
2. ↵
   Dawood MY, McGuire JL, Demers LM, eds. Premenstrual syndrome and dysmenorrhea. 1st ed. Baltimore: Urban & Schwarzenberg; 1985.
3. ↵
   Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol 1996; 87: 55–58.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   The Transdermal Nitroglycerine/Dysmenorrhoea Study Group. Transdermal nitroglycerine in the management of pain associated with primary dysmenorrhoea: a multinational pilot study. J Int Med Res 1997; 25: 41–4.

   OpenUrlAbstract/FREE Full Text
5. ↵
   Moya RA, Moisa CF, Morales F, Wynter H, Ali A, Narancio E. Transdermal glyceryl trinitrate in the management of primary dysmenorrhea. Int J Gynaecol Obstet 2000; 69: 113–8.

   OpenUrlCrossRefPubMed
6. ↵
   Boyd EM, Sheppard EP, Boyd CE. The pharmacological basis of the expectorant action of glyceryl guaiacolate. Appl Ther 1967; 9: 55–9.

   OpenUrlPubMed
7. ↵
   Plumb DC. Veterinary drug handbook. White Bear Lake (MN): PharmaVet Publishing; 1991. p. 116.
8. ↵
   Bush IM, inventor. Method for the treatment of urologic disorders. United States patent US 4822610. 1989 Apr 18.
9. ↵
   Rhodes J, Evans BK, Heatley RV. [For use of guaifenesin compounds for heartburn and constipation.] European Patent Office Bulletin 1982;82/27:pub.no. 0 055 313.
10. ↵
    Kippley J. The art of natural family planning. 4th ed. Cincinnati: The Couple to Couple League; 1996.
11. Check JH, Adelson HG, Chung-Hsiu W. Improvement of cervical factor with guaifenesin. Fertil Steril 1982; 37: 707–8.

    OpenUrlPubMedWeb of Science
12. Check JH. Successful pregnancy despite advanced age and elevated serum follicle stimulating hormone levels—a case report. Clin Exp Obstet Gynecol 2000; 27: 171–2.

    OpenUrlPubMed
13. ↵
    Faccioli G. Hormone dependence of human cervical mucus and variability of mucus canalization and crystallization during the menstrual cycle. Acta Eur Fertil 1984; 15: 43–9.

    OpenUrlPubMed
14. ↵
    Auclair JM, Anton JP, Bellocq J, Zylberberg B. [Study of the action of the association of glyceric ether of guaiacol and camylofine on the dilatation of the cervix during the labor]. Rev Fr Gynecol Obstet 1970; 65: 523–8.

    OpenUrlPubMed
15. ↵
    Anglade JP, Monteil L, Cherasse A. [Trial of an injectable antispasmodic agent, Dilavacol, during delivery (apropos of 50 cases)]. Therapie 1971; 26: 431–8.

    OpenUrlPubMed
16. ↵
    Ratkóci I, Doszpod J, Bognár J. Effect of guaiphenesin on labour. Acta Chir Acad Sci Hung 1967; 8: 191–4.

    OpenUrlPubMed
17. ↵
    Perlík F, Janku I, Kordač V. The effect of guaiphenesin on absorption and bioavailability of paracetamol from composite analgesic preparations. Int J Clin Pharmacol Ther Toxicol 1988; 26: 413–6.

    OpenUrlPubMed
18. ↵
    Kraus I, Horský A, Presl J, et al. [Combined treatment of idiopathic dysmenorrhoea by acetylsalicylic acid and guaiphenezine.] Csek Gynekol 1981; 46: 601–5.

    OpenUrl
19. ↵
    Fedele L, Marchini M, Acaia B, Garagiola U, Tiengo M. Dynamics and significance of placebo response in primary dysmenorrhea. Pain 1989; 36: 43–7.

    OpenUrlCrossRefPubMedWeb of Science
20. ↵
    Smith RP. Objective changes in intrauterine pressure during placebo treatment of dysmenorrhea. Pain 1987; 29: 59–66.

    OpenUrlPubMed
21. ↵
    Brodie EE, Niven CA. Remembering an everyday pain: the role of knowledge and experience in the recall of the quality of dysmenorrhea. Pain 2000; 84: 89–94.

    OpenUrlPubMed